<SEC-DOCUMENT>0001140361-26-017651-index.html : 20260429
<SEC-HEADER>0001140361-26-017651.hdr.sgml : 20260429
<ACCEPTANCE-DATETIME>20260429081501
ACCESSION NUMBER:		0001140361-26-017651
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260429
DATE AS OF CHANGE:		20260429
EFFECTIVENESS DATE:		20260429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Compass Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001738021
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39696
		FILM NUMBER:		26910669

	BUSINESS ADDRESS:	
		STREET 1:		80 GUEST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02135
		BUSINESS PHONE:		617-500-8099

	MAIL ADDRESS:	
		STREET 1:		80 GUEST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02135

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Olivia Ventures, Inc.
		DATE OF NAME CHANGE:	20180419
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>edge20068103x3_ars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: edge20068103x3_ars.pdf

</DOCUMENT>
</SEC-DOCUMENT>